Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs

被引：9

作者：

Benfaremo, Devis ^{[1
]}

Luchetti, Michele Maria ^{[1
]}

Gabrielli, Armando ^{[1
]}

机构：

[1] Univ Politecn Marche, Med Clin, Dipartimento Sci Clin & Mol, Ancona, Italy

来源：

JOURNAL OF IMMUNOLOGY RESEARCH | 2019年 / 2019卷

关键词：

ANKYLOSING-SPONDYLITIS;

D O I：

10.1155/2019/8630871

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Inflammatory bowel disease-associated spondyloarthritis is a systemic disease characterized by the chronic inflammation of both the gastrointestinal tract and the musculoskeletal system. Since inflammatory bowel disease-associated spondyloarthritis has been associated with a significant diagnostic delay, which may lead to poor quality of life and progression of joint damage, efforts to discover new reliable and noninvasive diagnostic biomarkers have been made. We reviewed the state of the art of biomarker research in inflammatory bowel disease-associated spondyloarthritis, showing that to date it has been largely unsatisfactory. Only a few of the biomarkers that have been investigated are likely to enter the clinical practice upon further validation in independent cohorts. The research of new and innovative biomarkers for inflammatory bowel disease-associated spondyloarthritis is warranted.

引用

页数：10

共 102 条

[1] Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis [J].

Al-Jarallah, Khaled ;

Shehab, Diaa ;

Al-Attiyah, Rajaa ;

Al-Azmi, Waleed ;

Al-Fadli, Ahmad ;

Haider, Mohammed Zafar ;

Panaccione, Remo ;

Ghosh, Subrata .

INFLAMMATORY BOWEL DISEASES, 2012, 18 (09) :1655-1662

[2] Altered Skeletal Expression of Sclerostin and Its Link to Radiographic Progression in Ankylosing Spondylitis [J].

Appel, Heiner ;

Ruiz-Heiland, Gisela ;

Listing, Joachim ;

Zwerina, Jochen ;

Herrmann, Martin ;

Mueller, Ruediger ;

Haibel, Hildrun ;

Baraliakos, Xenofon ;

Hempfing, Axel ;

Rudwaleit, Martin ;

Sieper, Joachim ;

Schett, Georg .

ARTHRITIS AND RHEUMATISM, 2009, 60 (11) :3257-3262

[3] Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis [J].

Arends, Suzanne ;

van der Veer, Eveline ;

Groen, Henk ;

Houtman, Pieternella M. ;

Jansen, Tim L. T. A. ;

Leijsma, Martha K. ;

Bijzet, Johan ;

Limburg, Pieter C. ;

Kallenberg, Cees G. M. ;

Spoorenberg, Anneke ;

Brouwer, Elisabeth .

JOURNAL OF RHEUMATOLOGY, 2011, 38 (08) :1644-1650

[4] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].

Atkinson, AJ ;

Colburn, WA ;

DeGruttola, VG ;

DeMets, DL ;

Downing, GJ ;

Hoth, DF ;

Oates, JA ;

Peck, CC ;

Schooley, RT ;

Spilker, BA ;

Woodcock, J ;

Zeger, SL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95

[5] Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies:: a reassessment [J].

Aydin, S. Z. ;

Atagunduz, P. ;

Temel, M. ;

Bicakcigil, M. ;

Tasan, D. ;

Direskeneli, H. .

RHEUMATOLOGY, 2008, 47 (02) :142-144

[6] Autoantibodies against CD74 in spondyloarthritis [J].

Baerlecken, N. T. ;

Nothdorft, S. ;

Stummvoll, G. H. ;

Sieper, J. ;

Rudwaleit, M. ;

Reuter, S. ;

Matthias, T. ;

Schmidt, R. E. ;

Witte, T. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) :1211-1214

[7] Ankylosing spondylitis and bowel disease [J].

Baeten, D ;

De Keyser, F ;

Mielants, H ;

Veys, EM .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (04) :537-549

[8]

Bandinelli F, 2014, CLIN EXP RHEUMATOL, V32, P949

[9] Ultrasound discloses entheseal involvement in inactive and low active inflammatory bowel disease without clinical signs and symptoms of spondyloarthropathy [J].

Bandinelli, Francesca ;

Milla, Monica ;

Genise, Stefania ;

Giovannini, Leonardo ;

Bagnoli, Siro ;

Candelieri, Antonio ;

Collaku, Ledio ;

Biagini, Silvia ;

Cerinic, Marco Matucci .

RHEUMATOLOGY, 2011, 50 (07) :1275-1279

[10] High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis [J].

Baraliakos, X. ;

Baerlecken, N. ;

Witte, T. ;

Heldmann, F. ;

Braun, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) :1079-1082

← 1 2 3 4 5 6 7 8 9 10 →